Cargando…
Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro
We recently described that the anti-apoptotic AMPK-related kinase, SNARK, promotes transforming growth factor (TGF)-β signaling in hepatocellular carcinoma (HCC) cells, as a potentially new therapeutic target. Here we explored FDA-approved drugs inhibiting the enzymatic activity of SNARK, using an i...
Autores principales: | Goto, Kaku, Kato, Naoya, Chung, Raymond T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342717/ https://www.ncbi.nlm.nih.gov/pubmed/27602492 http://dx.doi.org/10.18632/oncotarget.11820 |
Ejemplares similares
-
Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
por: Goto, Kaku, et al.
Publicado: (2018) -
The Snark was a Boojum - reloaded
por: Macrì, Simone, et al.
Publicado: (2015) -
Of snarks, boojums and national drug charts
por: Barber, Nick, et al.
Publicado: (2013) -
Phenotyping the Snark: hazards of 3D
por: Bell, Graham
Publicado: (2016) -
Disulfiram Treatment of Alcoholism
por: Anton, Raymond F.
Publicado: (1995)